Kami mempelawa individu-individu yang dinamik, bercita-cita tinggi dan bertanggungjawab serta bersedia untuk bekerja keras menyertai organisasi kami bagi jawatan Eksekutif Sumber Manusia (Kontrak) di Pejabat Korporat NIBM, Serdang
Jawatan:
1. Ketua Program
(Pusat Bioteknologi Haiwan)
*Sila baca syarat kelayakan dan maklumat lain sebelum memohon melalui link di bawah
(Pusat Bioteknologi Haiwan)
2. Ketua Program
(Pusat Bioteknologi Makanan, Biofungsian & Bioproses)
3. Ketua Program
(Biologi Pengkomputeran) (Computational Biology)
*Sila baca syarat kelayakan dan maklumat lain sebelum memohon melalui link di bawah
Cara Memohon:
Calon-calon yang memenuhi keperluan dan syarat-syaratkelayakan yang tertera di atas dijemput menghantar resume yang lengkap dengan menyertakan butir-butir peribadi, kelayakan serta pengalaman, nombor telefon untuk dihubungi, salinan sijil-sijil berkaitan yang telah disahkan serta
sekeping gambar berukuran passport (tidak dikembalikan) kepada:
BAHAGIAN SUMBER MANUSIA,
NATIONAL INSTITUTES OF BIOTECHNOLOGY MALAYSIA,
Pejabat Korporat, Aras 2,
Kompleks Agro-Biotechnology Institute (ABI),
d/a Ibupejabat MARDI, 43400 Serdang, Selangor.
Tel : 03-8949 5687
Emel :recruitment@nibm.my
Hanya calon-calon yang disenarai pendek sahaja akan dihubungi.
Tarikh tutup permohonan: 13 Jun 2016
About NIBM
Healthcare biotechnology serves a pivotal role in the realization of the National Biotechnology Policy (NBP) devised in 2005. The abundance of natural resources found within our borders will serve to drive biotechnology as a new economic engine in the near future. Following a decision by the Cabinet on the implementation of the NBP (Memorandum MOSTI No. 882/2534/2006), the Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm) was established on 29th November 2006 under the Ministry of Science, Technology and Innovation in order to spearhead this initiative by delivering world-class R&D to accelerate the discovery, development and commercialization of pharmaceutical and nutraceutical products.
Tun Dato' Sri Haji Abdullah bin Haji Ahmad during BioMalaysia Conference on 28 April 2005 at Putrajaya International Conference Centre. This policy, endorsed by the Malaysian Cabinet on 20 April 2015 emphasises on the development of three core areas of biotechnology, namely the agriculture, healthcare and industry. Under NBP's Healthcare Biotechnology thrust, the government aspire to get benefit from country's enviable wealth in natural resources especially in drug discovery and development. Concurrently, the potential of bio-generics market is also recognized as an important area in healthcare biotechnology. Realizing the challenges in developing the healthcare biotechnology is competitive, the Cabinet endorsed the proposal to establish a centre of excellence. This historical decision marks the birth of the Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm).
Kerja Kosong Terkini NIMB
The establishment of the IPharm was approved by the Biotechnology Implementation Council on 7 September 2006 and approved by the Cabinet on 26 November 2006 with two other institutions namely Agro Biotechnology Institute (ABI) and the Malaysian Genome Institute (MGI) under the Ministry of Science, Technology and Innovation.IPharm research facility, previously located within Universiti Sains Malaysia (USM) campus in Pulau Pinang, was relocated to the interim research facility namely SAINS@USM Complex located at Bukit Jambul, Pulau Pinang in 2008. Then, in 2011 IPharm has its own building complex strategically located in Halaman Bukit Gambir, Pulau Pinang with area of 10 acres. IPharm was established as a centre of excellence to spearhead the NBP thrusts by delivering world class R&D in order to accelerate the discovery, development and commercialisation of pharmaceutical and nutraceutical products as well as to build the nation's skilled human resources in Healthcare Biotechnology.In 1 March 2014, all the three institutes established under NBP (IPharm, ABI and MGI) had been transformed and incorporated as National Institutes of Biotechnology Malaysia (NIBM), a not for profit government organisation operating as Company Limited by Guarantee (CLG). This transformation is a move forward for IPharm in ensuring its vision of becoming a Center of Excellence in research and development in healthcare biotechnology become reality. By this transformation, it is hoped that IPharm will be more independent, surge forward with more proactive and dynamic and focus on revenue generation process which include in the production of products and services.